Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Hochman Insider Profile
4 Followers
David Hochman, Director at Corbus Pharmaceuticals, holds 914.64K shares in Orchestra BioMed Holdings (Ticker: OBIO), holds 2.47M shares in Motus Gi Holdings (Ticker: MOTS), holds 1.05M shares in Corbus Pharmaceuticals (Ticker: CRBP). Most recently, David Hochman Bought ― shares of Orchestra BioMed Holdings on Sep 26, 2024 for an estimated value of 47.91K.
Profitable Transactions
6 out of 22 Profitable Transactions
Average Return
-10.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Hochman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 18, 2015 - Aug 18, 2016
Return:+94.00%
The most profitable trade made by David Hochman
David Hochman's Trading History
Corbus Pharmaceuticals
Mar 18, 2019
Director
Informative Buy
13.94K
$18.27M
Motus Gi Holdings
Jan 07, 2022
Director, Chairman of the Board
Uninformative Buy
―
$81.50K
Orchestra BioMed Holdings
Sep 26, 2024
CEO and Chairperson, Director
Informative Buy
47.91K
$5.28M
List of latest transactions for each holding click on a transaction to see David Hochman's performance on stock
You May Also Like
David Hochman insider profile FAQ
What is the percentage of profitable transactions made by David Hochman?
The percentage of profitable transactions made by David Hochman is 27%.
What is the average return per transaction made by David Hochman?
The average return per transaction made by David Hochman is -10.70%.
What stocks does David Hochman hold?
David Hochman holds: CRBP, MOTS, OBIO stocks.
What was David Hochman’s latest transaction?
David Hochman latest transaction was an Informative Buy of $47.91K.
What was David Hochman's most profitable transaction?
David Hochman’s most profitable transaction was an Informative Buy of CRBP stock on August 18, 2015. The return on the trade was 94.00%.
What is David Hochman's role in Corbus Pharmaceuticals?
David Hochman's role in Corbus Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.